GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
21:05 Aug 8, 2016 |
Serbian to English translations [PRO] Medical - Medical (general) | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Colaris Serbia Local time: 19:06 | ||||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
5 | Peritonealna dijaliza (PD) / Peritoneal dyalisis |
| ||
3 | personalizirana dijagnostika/personalized diagnostics |
|
Discussion entries: 8 | |
---|---|
Peritonealna dijaliza (PD) / Peritoneal dyalisis Explanation: https://books.google.rs/books?isbn=0323074030 - https://sh.wikipedia.org/wiki/Peritonealna_dijaliza |
| |
Grading comment
| ||
Login to enter a peer comment (or grade) |
personalizirana dijagnostika/personalized diagnostics Explanation: po kontekstu bi trebalo biti to individualan pristup PD Pogledajte reference: http://www.roche.hr/home/personalizirana-medicina.html http://pravri.uniri.hr/files/savjetovanja/medicina15.pdf Praćenje terapije - Nakon završetka terapije definisati odgovor na terapiju i ustanoviti MRB - CR i CRu - praćenje na 3 mjeseca/ 24 mjeseca - praćenje na 6 mjeseci/ 36 mjeseci PR i PD nastavlja se terapija kao kod relapsa ili RT Terapija relapsa/raktarna bolest Pacijenti koji su kandidati za HDT - R- DHAP ( rituximab, dexamethason,cisplatin,cytarabin) - R- ESHAP(rituximab, etopozid,methylprednisolone,cytarabine,cisplatin) - R- ICE( rituximab, ifosfamid,carboplatin,etopozid) - miniBEAM(carmustine,etopozide,cytarabine,melphalan)+/-R - MINE ( mesna,ifosfamide,mitoxantrone,etopozide)+/-R. CR ili PR - konsolidaciona terapija ASCT +/- RT , dodatna RT može se poslije ASCT na mjesto bulky - nisu kandidati za ASCT terapiju: kliničke studije ili individualan pristup PD - Bez odgovora: najbolja suportivna njega http://www.uhit.ba/pdf/smjernice-limfomi.pdf |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.